Antibody Demonstrates Potential to Treat Rare Form of Psoriasis

The New England Journal of Medicine recently published new data from a Phase I clinical trial suggesting that BI 655130, a first-in-class investigational treatment, significantly improved symptoms of generalized pustular psoriasis (GPP), a rare form of psoriasis.